[144] F&G Annuities & Life, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for F&G Annuities & Life, Inc. (FGSN) describes a proposed sale of 3,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $101,430. The filer reports total outstanding shares of 134,648,802 and an approximate sale date of 09/18/2025. The 3,000 shares were acquired by restricted stock vesting from the issuer on 02/28/2025 and were received as compensation. The filing shows "Nothing to Report" for securities sold by the person in the past three months. Several filer identification fields (CIK/name/contact) and issuer address details are not populated in the provided content.

Positive

• Transaction details provided: the form specifies number of shares, aggregate market value, broker, exchange, and approximate sale date
• Acquisition source disclosed: shares were acquired via restricted stock vesting on 02/28/2025 and paid as compensation

Negative

• Missing filer/issuer identification fields in the provided extract (CIK, filer name, issuer address/contact details are not populated)
• No signature or filer contact details visible in the supplied content, requiring verification of the complete EDGAR filing

Insights

Financial Analyst

TL;DR: A small, routine insider sale notice: 3,000 vested shares listed for potential sale, limited apparent market impact given company size.

The Form 144 documents a planned disposition of 3,000 common shares valued at $101,430 through Fidelity on the NYSE, originating from restricted stock that vested on 02/28/2025 and was paid as compensation. Relative to the reported 134.65 million outstanding shares, this block represents a very small percentage of the float. The filing does not disclose other recent sales by the person and omits identifying filer details in the provided extract. For investors, this appears to be a routine post-vesting sale notice rather than a signal of material change in corporate fundamentals.

Corporate Governance / Compliance Specialist

TL;DR: Form 144 appears procedurally complete for the listed trade but lacks some identifying issuer/filer contact details in this extract.

The form records acquisition details (restricted stock vesting on 02/28/2025) and intended sale mechanics (broker, date, exchange). It includes the standard representation that the seller is not aware of undisclosed material adverse information and notes no securities sold in the prior three months. The absence of filer CIK/name and issuer contact fields in the provided content means reviewers should confirm the complete filing in EDGAR to verify signatures and contact data before relying on it for compliance or disclosure purposes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	101430.00	134648802	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2025	Restricted Stock Vesting	Issuer			3000	02/28/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for FGSN report?

The filing reports a proposed sale of 3,000 common shares through Fidelity on the NYSE with an aggregate market value of $101,430 and an approximate sale date of 09/18/2025.

How and when were the shares reported on Form 144 acquired?

The 3,000 shares were acquired by restricted stock vesting from the issuer on 02/28/2025 and were received as compensation.

What percentage of outstanding shares does the proposed sale represent?

The filing lists 134,648,802 shares outstanding; the 3,000-share block is a very small fraction of that total (the filing provides both figures).

Does the Form 144 show prior sales by the person in the past three months?

The filing states "Nothing to Report" for securities sold by the person during the past three months.

Are there any compliance or disclosure caveats visible in this extract?

Yes. The provided content does not display filer identification (CIK/name) or signature/contact details, so the complete EDGAR record should be checked to confirm the filing's procedural completeness.